Global pharmaceutical giant Boehringer Ingelheim has signed a new five-year contract with Omnicom’s OMD, extending and expanding the agency’s media services remit for human and animal health in the US and animal health in more than 30 markets worldwide through 2029.
The new agreement, which builds on a relationship that began in 2020, expands the agency’s remit to include commerce, search, and healthcare professional-focused media in the U.S.